These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26418699)

  • 1. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
    Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
    Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin dosing in neutropenic patients.
    Haeseker MB; Croes S; Neef C; Bruggeman CA; Stolk LM; Verbon A
    PLoS One; 2014; 9(11):e112008. PubMed ID: 25390637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pharmacokinetic Outcomes of Peak-Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial.
    Al-Sulaiti FK; Nader AM; Saad MO; Shaukat A; Parakadavathu R; Elzubair A; Al-Badriyeh D; Elewa H; Awaisu A
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):639-652. PubMed ID: 30919233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.
    Wong S; Selby PR; Reuter SE
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1231. PubMed ID: 38940223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2014 Aug; 53(8):753-62. PubMed ID: 24989061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients.
    Bel Kamel A; Bourguignon L; Marcos M; Ducher M; Goutelle S
    Ther Drug Monit; 2017 Feb; 39(1):83-87. PubMed ID: 27861313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics and impact indicator of vancomycin pharmacokinetics in cancer patients complicated with severe pneumonia.
    Zhang X; Wang D
    J Infect Chemother; 2020 May; 26(5):492-497. PubMed ID: 31983615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Yasukawa M; Inoue T; Murase M; Araki H
    Int J Clin Pharmacol Ther; 2007 Nov; 45(11):592-7. PubMed ID: 18077923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
    Rao Z; Guo SM; Wei YM
    Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
    AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
    Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
    J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of vancomycin loading doses in intermittent infusion regimens.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.
    Prybylski JP
    Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.